reviewAnnals of the Rheumatic DiseasesMar 6, 2017BRONZE OA

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

JSJosef S SmolenRLRobert LandewéJBJohannes BijlsmaGBGerd BurmesterKCKaterina Chatzidionysiou

Klinik Hietzing · Medical University of Vienna · +56 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

5,767
total citations
FWCI
525.46
Percentile
100%
References
383
Citations per year

Authors

49

Topics & keywords

Topics
Keywords
  • Medicine
  • Abatacept
  • Adalimumab
  • Certolizumab pegol
  • Tocilizumab
  • Infliximab
  • Golimumab
  • Etanercept
No related works found for this paper.

Funding